4218 items matching your search terms.

Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311

Ackland, S. P. Gebski, V. Zdenkowski, N. Wilson, A. Green, M. Tees, S. Dhillon, H. Van Hazel, G. Levi, J. Simes, R. J. Forbes, J. F. Coates, A. S. for Breast Cancer Trials, Ltd
BREAST CANCER RESEARCH AND TREATMENT, 2019     DOI:10.1007/s10549-019-05187-y

High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes

Ahmadzada, T. Lee, K. Clarke, C. Cooper, W. A. Linton, A. McCaughan, B. Asher, R. Clarke, S. Reid, G. Kao, S.
LUNG CANCER, 2019     DOI:10.1016/j.lungcan.2019.02.005

Association of Supine Going-to-Sleep Position in Late Pregnancy With Reduced Birth Weight: A Secondary Analysis of an Individual Participant Data Meta-analysis

Anderson, N. H. Gordon, A. Li, M. Cronin, R. S. Thompson, J. M. D. Raynes-Greenow, C. H. Heazell, A. E. P. Stacey, T. Culling, V. M. Wilson, J. Askie, L. M. Mitchell, E. A. McCowan, L. M. E.
JAMA NETW OPEN, 2019     DOI:10.1001/jamanetworkopen.2019.12614

Meta-analysis of Oxygenation Saturation Targeting Trials: Do Infant Subgroups Matter?

Askie, L. M.
CLINICS IN PERINATOLOGY, 2019     DOI:10.1016/j.clp.2019.05.003

Integrating diabetic retinopathy screening within diabetes education services in Australia's diabetes and indigenous primary care clinics

Atkinson-Briggs, S. Jenkins, A. Keech, A. Ryan, C. Brazionis, L. Centre of Research Excellence in Diabetic, Retinopathy
INTERNAL MEDICINE JOURNAL, 2019     DOI:10.1111/imj.14309

Associations between circulating inflammatory markers, diabetes type and complications in youth

Aulich, J. Cho, Y. H. Januszewski, A. S. Craig, M. E. Selvadurai, H. Wiegand, S. Jenkins, A. J. Donaghue, K. C.
PEDIATR DIABETES, 2019     DOI:10.1111/pedi.12913

Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation

Back, M. Jayamanne, D. Brazier, D. Newey, A. Bailey, D. Schembri, G. Hsiao, E. Khasraw, M. Wong, M. Kastelan, M. Brown, C. Wheeler, H.
STRAHLENTHERAPIE UND ONKOLOGIE, 2019     DOI:10.1007/s00066-019-01467-0

Phlda3 regulates beta cell survival during stress

Bensellam, M. Chan, J. Y. Lee, K. Joglekar, M. V. Hardikar, A. A. Loudovaris, T. Thomas, H. E. Jonas, J. C. Laybutt, D. R.
SCI REP, 2019     DOI:10.1038/s41598-019-49289-5

A cross-sectional audit showed that most Cochrane intervention reviews searched trial registers

Berber, S. Tan-Koay, A. G. Opiyo, N. Dwan, K. Glanville, J. M. Lasserson, T. J. Willson, M. L.
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2019     DOI:10.1016/j.jclinepi.2019.05.020

Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review

Bracken, K. Askie, L. Keech, A. C. Hague, W. Wittert, G.
BMJ OPEN, 2019     DOI:10.1136/bmjopen-2018-025580

Phone reminders did not increase screening uptake more than SMS reminders: a recruitment study-within-a-trial (SWAT)

Bracken, K. Keech, A. Hague, W. Kirby, A. Robledo, K. P. Allan, C. Conway, A. Daniel, M. Gebski, V. Grossmann, M. Handelsman, D. J. Inder, W. Jenkins, A. McLachlan, R. Stuckey, B. Yeap, B. B. Wittert, G.
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2019     DOI:10.1016/j.jclinepi.2019.04.009

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

Bracken, K. Hague, W. Keech, A. Conway, A. Handelsman, D. J. Grossmann, M. Jesudason, D. Stuckey, B. Yeap, B. B. Inder, W. Allan, C. McLachlan, R. Robledo, K. P. Wittert, G.
TRIALS, 2019     DOI:10.1186/s13063-019-3485-2

A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial

Bracken, K. Keech, A. Hague, W. Allan, C. Conway, A. Daniel, M. Gebski, V. Grossmann, M. Handelsman, D. J. Inder, W. J. Jenkins, A. McLachlan, R. Robledo, K. P. Stuckey, B. Yeap, B. B. Wittert, G.
CLINICAL TRIALS, 2019     DOI:10.1177/1740774519872999

Treatments used for obsessive-compulsive disorder-An international perspective

Brakoulias, V. Starcevic, V. Albert, U. Arumugham, S. S. Bailey, B. E. Belloch, A. Borda, T. Dell'Osso, L. Elias, J. A. Falkenstein, M. J. Ferrao, Y. A. Fontenelle, L. F. Jelinek, L. Kalogeraki, L. Kay, B. Laurito, L. D. Lochner, C. Maina, G. Marazziti, D. Martin, A. Matsunaga, H. Miguel, E. C. Morgado, P. Mourikis, I. Pasquini, M. Perez Rivera, R. Potluri, S. Reddy, J. Y. C. Riemann, B. C. do Rosario, M. C. Shavitt, R. G. Stein, D. J. Viswasam, K. Wang, Z. Fineberg, N. A.
HUMAN PSYCHOPHARMACOLOGY, 2019     DOI:10.1002/hup.2686

Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT)

Butcher, N. J. Monsour, A. Mew, E. J. Szatmari, P. Pierro, A. Kelly, L. E. Farid-Kapadia, M. Chee, A. Tow A. Saeed, L. Monga, S. Ungar, W. Terwee, C. B. Vohra, S. Fergusson, D. Askie, L. M. Williamson, P. R. Chan, A. W. Moher, D. Offringa, M.
TRIALS, 2019     DOI:10.1186/s13063-019-3248-0